Join Us at Noon ET/9 am PT for a Tweetchat on the Biotech VC Crisis With Daphne Zohar

Just a quick reminder here to join us for the Tweetchat today with Daphne Zohar of PureTech Ventures. This chat, on the crisis in biotech venture capital, will be on Twitter today at Noon Eastern/9 am Pacific. I will be asking questions from @ldtimmerman and @xconomy while Zohar will be answering from her account (@daphnezohar).You can keep track of all the back-and-forth under the searchable hash tag #bioVC.

If you’ve got questions about what’s going on in venture capital, and what kind of effect it is having on the biotech community, this is a great opportunity to ask for an insider’s view. All you have to do is send a question in on Twitter. To make sure Zohar and everybody else on the chat sees it, be sure to type #bioVC at the end. We’ll go for about 30 minutes.

See you online at Noon ET/9 am PT.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.